Published in FEBS Lett on November 02, 1992
Keratocan, a cornea-specific keratan sulfate proteoglycan, is regulated by lumican. J Biol Chem (2005) 1.83
Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease. Hepatology (2009) 1.21
Identification of vitamin A-free cells in a stellate cell-enriched fraction of normal rat liver as myofibroblasts. Histochem Cell Biol (2006) 1.08
Lumican is required for neutrophil extravasation following corneal injury and wound healing. J Cell Sci (2010) 0.98
Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis. Lab Invest (2012) 0.89
A comprehensive analysis of the dynamic biological networks in HCV induced hepatocarcinogenesis. PLoS One (2011) 0.85
Immunohistochemical expression and distribution of proteoglycans and collagens in sclerocornea. Int Ophthalmol (2013) 0.84
Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma. Cancer Microenviron (2010) 0.83
Fibromodulin, an oxidative stress-sensitive proteoglycan, regulates the fibrogenic response to liver injury in mice. Gastroenterology (2011) 0.82
Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues. World J Gastroenterol (2012) 0.81
Proteoglycans in liver cancer. World J Gastroenterol (2016) 0.78
The phosphorylation of liver ribosomal proteins in vivo. Evidence that only a single small subunit protein (S6) is phosphorylated. J Biol Chem (1974) 2.40
Practical implications of coexistent different technologies in clinical chemical laboratories. Solid phase chemistry and conventional analysis. Eur J Clin Chem Clin Biochem (1991) 1.96
Modulation of transforming growth factor beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology (2000) 1.84
The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology (1987) 1.84
Activation of rat liver perisinusoidal lipocytes by transforming growth factors derived from myofibroblastlike cells. A potential mechanism of self perpetuation in liver fibrogenesis. J Clin Invest (1992) 1.62
Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol (1992) 1.51
Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol (1997) 1.51
[The clinical value of laminin determination in advanced liver cirrhosis]. Dtsch Med Wochenschr (1996) 1.39
Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. Clin Chem (1997) 1.35
Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology (2001) 1.29
Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells. Hepatology (2006) 1.28
Pharmacological aspects of pentoxifylline with emphasis on its inhibitory actions on hepatic fibrogenesis. Gen Pharmacol (1997) 1.28
Tumor-dependent activation of rodent hepatic stellate cells during experimental melanoma metastasis. Hepatology (1997) 1.23
Transformation-dependent susceptibility of rat hepatic stellate cells to apoptosis induced by soluble Fas ligand. Hepatology (1998) 1.19
Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells. Growth Factors (2005) 1.18
Tumor necrosis factor alpha (TNF alpha) and transforming growth factor beta 1 (TGF beta 1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 1.15
Influence of glucagon and cyclic adenosine 3':5'-monophosphate on the phosphorylation of rat liver ribosomal protein S6. J Biol Chem (1976) 1.11
Thrombospondin 1 acts as a strong promoter of transforming growth factor beta effects via two distinct mechanisms in hepatic stellate cells. Gut (2005) 1.11
Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med (2007) 1.07
Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture. Hepatology (2001) 1.06
The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet (2007) 1.06
Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis. J Viral Hepat (2009) 1.05
Molecular and functional aspects of latent transforming growth factor-beta binding protein: just a masking protein? Cell Tissue Res (1999) 1.04
The stimulation of the phosphorylation of ribosomal protein S6 by cycloheximide and puromycin. Biochem Biophys Res Commun (1974) 1.03
Serum concentrations of laminin and aminoterminal propeptide of type III procollagen in relation to the portal venous pressure of fibrotic liver diseases. Clin Chim Acta (1986) 1.00
Rapid genotyping of hemochromatosis gene mutations on the LightCycler with fluorescent hybridization probes. Clin Chem (1999) 0.99
Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver. J Am Soc Nephrol (2001) 0.99
Serum laminin and hyaluronan in liver cirrhosis: markers of progression with high prognostic value. J Hepatol (1996) 0.98
Interaction of synthetic polynucleotides with small rat liver ribosomal subunits possessing low and highly phosphorylated protein S6. Biochim Biophys Acta (1980) 0.97
Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation. Clin Biochem (2007) 0.97
Hepatic stellate cells display a functional vascular smooth muscle cell phenotype in a three-dimensional co-culture model with endothelial cells. Differentiation (2008) 0.97
Fibroblast growth factor 16 and 18 are expressed in human cardiovascular tissues and induce on endothelial cells migration but not proliferation. Biochem Biophys Res Commun (2006) 0.97
Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts. Biochem Biophys Res Commun (2001) 0.94
LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1. Biochem J (2001) 0.94
Effect of experimental diabetes and insulin on phosphorylation of rat liver ribosomal protein S6. Nature (1976) 0.93
Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha. Biochem Biophys Res Commun (1990) 0.93
Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J Cell Mol Med (2006) 0.93
Fibronectin is synthesized as an acute phase reactant in rat hepatocytes. J Clin Chem Clin Biochem (1986) 0.93
(Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology (1998) 0.93
Measurement of proteins with the Behring Nephelometer. A multicentre evaluation. J Clin Chem Clin Biochem (1989) 0.92
Liver fat storing cell proliferation is stimulated by epidermal growth factor/transforming growth factor alpha and inhibited by transforming growth factor beta. Biochem Biophys Res Commun (1989) 0.92
Characterization of insulin-like growth factor (IGF)-I-receptor binding sites during in vitro transformation of rat hepatic stellate cells to myofibroblasts. Eur J Clin Chem Clin Biochem (1996) 0.92
Insulin-like growth factor signaling pathways in rat hepatic stellate cells: importance for deoxyribonucleic acid synthesis and hepatocyte growth factor production. Endocrinology (1999) 0.91
Induction of neutrophil-attracting chemokines in transforming rat hepatic stellate cells. Gastroenterology (1997) 0.91
Preventive effects of acute inflammation on liver cell necrosis and inhibition of heparan sulphate synthesis in hepatocytes. J Clin Chem Clin Biochem (1986) 0.90
Quantitative monitoring of the mRNA expression pattern of the TGF-beta-isoforms (beta 1, beta 2, beta 3) during transdifferentiation of hepatic stellate cells using a newly developed real-time SYBR Green PCR. Biochem Biophys Res Commun (2002) 0.89
Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells. Hepatology (1998) 0.89
Logistic-regression model for assessing portal hypertension by measuring hyaluronic acid (hyaluronan) and laminin in serum. Clin Chem (1991) 0.89
The role of thrombocytes in liver fibrogenesis: effects of platelet lysate and thrombocyte-derived growth factors on the mitogenic activity and glycosaminoglycan synthesis of cultured rat liver fat storing cells. J Clin Chem Clin Biochem (1989) 0.88
The response of rat liver perisinusoidal lipocytes to polypeptide growth regulator changes with their transdifferentiation into myofibroblast-like cells in culture. J Hepatol (1993) 0.88
Insulin-like growth factors stimulate expression of hepatocyte growth factor but not transforming growth factor beta1 in cultured hepatic stellate cells. Endocrinology (1997) 0.87
Enhancing filtration rates by the use of blood flow around the capillaries of plasmafilters: an in vitro study. Int J Artif Organs (2001) 0.87
The chemical morphology of extracellular matrix in experimental rat liver fibrosis resembles that of normal developing connective tissue. Virchows Arch (1994) 0.87
Evaluation of a new, rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem (2001) 0.86
Expression of isoforms and splice variants of the latent transforming growth factor beta binding protein (LTBP) in cultured human liver myofibroblasts. Liver (2001) 0.86
Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem (2000) 0.86
Comparative analysis of adenoviral transgene delivery via tail or portal vein into rat liver. Arch Virol (2004) 0.86
Biglycan and decorin gene expression in normal and fibrotic rat liver: cellular localization and regulatory factors. Hepatology (1992) 0.86
Proliferation of fat-storing cells is stimulated by secretions of Kupffer cells from normal and injured liver. Exp Mol Pathol (1988) 0.85
Expression of different isoforms of TGF-beta and the latent TGF-beta binding protein (LTBP) by rat Kupffer cells. J Hepatol (1998) 0.85
The prognostic value of extracellular matrix component concentrations in serum during treatment of adult respiratory distress syndrome with extracorporeal CO2 removal. Eur J Clin Chem Clin Biochem (1991) 0.85
Identification of an unconventional nuclear localization signal in human ribosomal protein S2. Biochem Biophys Res Commun (2005) 0.85
Gene expression of syndecans and betaglycan in isolated rat liver cells. Cell Tissue Res (1996) 0.85
Comparative evaluation of gene delivery devices in primary cultures of rat hepatic stellate cells and rat myofibroblasts. BMC Cell Biol (2000) 0.84
Influence of fibronectin on the motility of human spermatozoa. Int J Androl (1997) 0.84
The cysteine- and glycine-rich LIM domain protein CRP2 specifically interacts with a novel human protein (CRP2BP). Biochem Biophys Res Commun (2000) 0.84
Efficacy of serum laminin measurement for diagnosis of fibrotic liver diseases. Clin Chem (1988) 0.83
[Fibronectin in human bile--a new parameter for diagnosis of malignant bile duct processes?--A pilot study]. Z Gastroenterol (1994) 0.83
Serum laminin--its concentration increases with portal hypertension in cirrhotic liver disease. Klin Wochenschr (1986) 0.83
Transforming growth factors (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells. FEBS Lett (1989) 0.83
Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver. Hepatology (1997) 0.82
Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells. J Hepatol (1999) 0.82
Isoforms and splice variant of transforming growth factor beta-binding protein in rat hepatic stellate cells. Gastroenterology (1998) 0.82
Transforming growth factor beta (TGF-beta) expression in isolated and cultured rat hepatocytes. J Cell Physiol (1996) 0.82
Transformation-dependent calcium influx by voltage-operated calcium channels in stellate cells of rat liver. J Hepatol (1999) 0.81
The up-and-down of hepatic stellate cells in tissue injury: apoptosis restores cellular homeostasis. Gastroenterology (2001) 0.80
[Elevated concentrations of fecal calprotectin in patients with liver cirrhosis]. Dtsch Med Wochenschr (2006) 0.80
The biosynthesis of glycosaminoglycans in normal rat liver and in response to experimental hepatic injury. Hoppe Seylers Z Physiol Chem (1977) 0.80
Serum concentrations of N-terminal propeptide of type III procollagen and laminin in the outflow of fibrotic livers compared with liver-distal regions. Hepatogastroenterology (1986) 0.80
[The clinical significance of sialic acid in the serum in benign and malignant disease]. J Clin Chem Clin Biochem (1987) 0.80
On the performance and reliability of mechanized urine teststrip measurement in comparison with visual reading. J Clin Chem Clin Biochem (1989) 0.79
Characterization of hepatocyte-derived mitogenic activity on hepatic stellate cells. Liver (2000) 0.79
Upregulation of pleiotrophin expression in rat hepatic stellate cells by PDGF and hypoxia: implications for its role in experimental biliary liver fibrogenesis. Biochem Biophys Res Commun (2005) 0.79
Schistosoma mansoni infection in a recently exposed community in Senegal: lack of correlation between liver morphology in ultrasound and connective tissue metabolites in serum. Trop Med Int Health (1998) 0.79
Hepatocyte-stimulated expression of hepatocyte growth factor (HGF) in cultured rat hepatic stellate cells. J Hepatol (1999) 0.79
Genomic locus and promoter region of rat Smad7, an important antagonist of TGFbeta signaling. Mamm Genome (2000) 0.79
De novo expression of glutamine synthetase during transformation of hepatic stellate cells into myofibroblast-like cells. Biochem J (1998) 0.78
Developmental changes of proteoglycan synthesis in rat liver and isolated hepatocytes. Mech Ageing Dev (1985) 0.78
Biosynthesis of small proteoglycans by hepatic lipocytes in primary culture. FEBS Lett (1989) 0.78
Binding of chondroitin sulfate, dermatan sulfate and fat-storing cell-derived proteoglycans to rat hepatocytes. Int J Biochem (1987) 0.78
Hepatic proteoglycans--a brief survey of their pathobiochemical implications. Hepatogastroenterology (1983) 0.78
Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhosis of equal severity. J Hepatol (1992) 0.78
N-terminal procollagen peptide and beta 2-microglobulin in synovial fluids from inflammatory and non-inflammatory joint diseases. Clin Chim Acta (1984) 0.78
Transformed fat storing cells inhibit the proliferation of cultured hepatocytes by secretion of transforming growth factor beta. J Hepatol (1990) 0.78
Amidolytic and immuno-nephelometric determination of alpha 1-proteinase inhibitor and alpha 2-macroglobulin in serum with calculation of specific inhibitor activities in health and disease. J Clin Chem Clin Biochem (1984) 0.78